Prof. Dr.rer.nat. Arli Aditya Parikesit, S.Si., M.Si. Nominated for Anugerah Diktisaintek 2025

Jakarta, Indonesia – September 2025 – i3L University proudly announces that Prof. Dr.rer.nat. Arli Aditya Parikesit, S.Si., M.Si., a leading faculty member in the Department of Bioinformatics, has been officially recommended by LLDIKTI Wilayah III to join the national level selection of Anugerah Diktisaintek di Bidang STEM 2025. Prof. Arli from i3L University has been nominated under the Best Senior Scientist category, while i3L University has also been nominated as one of the Most Productive Universities in STEM. This dual recognition highlights both individual excellence and institutional strength in advancing STEM research and innovation in Indonesia.

The Anugerah Diktisaintek is a prestigious award organized by the Ministry of Education, Culture, Research, and Technology (Kemendikbudristek) to honor outstanding contributions in science, technology, engineering, and mathematics (STEM). The award celebrates the work of scientists, researchers, and universities that significantly contribute to the development of Indonesia’s scientific and technological landscape.

Prof. Arli, a leading expert in bioinformatics, earned his doctoral degree (Dr.rer.nat.) in Germany and has built a distinguished career in structural bioinformatics, immunoinformatics, and biomedical research. His work integrates biology and computational science, contributing to advancements in drug discovery and molecular science. He is also widely recognized for mentoring future scientists and advancing Indonesia’s STEM capabilities.

“This recognition reflects our commitment to advancing scientific research and innovation,” said the i3L leadership. “We are proud of Prof. Arli’s achievements and the continued growth of i3L University as a leading center for STEM research.”

i3L University gives our best wishes to Prof. Arli on this prestigious nomination and looks forward to the national results of the Anugerah Diktisaintek 2025.

ABOUT BIOMEDICINE

i3L’s Biomedicine program focuses on research and innovation that bridges the study on human health and disease with therapeutic and diagnostic development. Currently, our program offers three specialization streams that focus on tumor biology, infectious disease, and bioinformatics. We utilize the triple-helix approach, which involves the interactions between academia, industry, and government, that strategies and implements the most relevant biomedicine research and development to the community.